Trial intelligence / Profile preview

Hemodynamic comparison of remimazolam vs propofol using LV pressure-volume analysis

jRCT1011250003Recruiting

Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing Remimazolam arm with Propofol arm (2 arms). Primary endpoints: Change in left ventricular end-diastolic volume, Change in effective arterial elastance and 1 more. Started Jul 2025; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on jRCT1011250003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1011250003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call